Published on: 26/12/2025
Effects of Cannabis on Adolescents: Brain Risks and Youth Usage Data
Cannabis is a topic that sparks heated debates, especially when it comes to its use among adolescents. With the evolution of legislation in many countries and the increasingly widespread perception of lower risk compared to other substances, more and more young people are coming into contact with this plant, often underestimating its effects.
Understanding how cannabis interacts with the developing brain, which substances it contains, how the endocannabinoid system works, and the actual scientific data on youth usage is essential for informing parents, educators, and adolescents themselves.
In this article, we will first explore the main substances present in cannabis, then the relationship between these substances and the human endocannabinoid system, the specific effects on adolescent brain development with scientific evidence, statistics on cannabis use among youth in Europe and worldwide, and finally, we will conclude with a reflection on risks, perspectives, and the importance of prevention.
Substances Contained in Cannabis
Cannabis is a complex plant that contains over 100 active chemical compounds, including cannabinoids and terpenes. The two main cannabinoids of interest for psychoactive and physiological effects are tetrahydrocannabinol (THC) and cannabidiol (CBD), though many others are present in smaller amounts.
THC is the substance primarily responsible for the psychotropic effects of cannabis — the “high” or altered perception commonly associated with recreational use. THC binds to cannabinoid receptors in the brain, influencing mood, memory, motor coordination, and other cognitive functions. THC levels vary widely among different cannabis strains and tend to be very high in today’s popular products, contributing to stronger psychoactive effects compared to traditional varieties.
CBD, on the other hand, is not psychoactive and may have anxiolytic or anti-inflammatory effects in some contexts, but it does not produce the perceptual alterations associated with THC. Lesser-known cannabinoids, such as cannabigerol (CBG) or cannabinol (CBN), play minor roles but can modulate the overall effects of the plant, particularly through a phenomenon known as the “entourage effect,” where multiple components interact synergistically.
Other compounds in cannabis include terpenes (such as myrcene, limonene, and pinene), which are not cannabinoids but can influence the aromatic profile and potentially certain biological effects. Overall, cannabis is a complex mixture, and the variability in its chemical composition is one of the main reasons why its effects can differ widely among users and products.
The Human Endocannabinoid System and Its Relationship with Cannabis Compounds
To understand how cannabis affects the human body, it is essential to discuss the endocannabinoid system (ECS), a biochemical network present in all mammals, including humans. This system consists of receptors (such as CB1 and CB2), endocannabinoids naturally produced by the body, and enzymes that regulate their synthesis and degradation.
The CB1 receptor is found in high concentrations in the brain and central nervous system. It regulates key processes such as mood, memory, appetite, pain, and motor control. The CB2 receptor is more prevalent in the immune system and can influence inflammation and immune responses.
The body produces its own natural cannabinoids (endocannabinoids), such as anandamide and 2-AG, which act as chemical messengers to maintain homeostasis — the balance necessary for normal physiological functioning. THC from cannabis binds to these same receptors, particularly CB1 in the brain, partially mimicking their action but in a more potent and less regulated manner, producing effects ranging from euphoria to sedation, as well as temporary cognitive impairments.
In adolescents, the endocannabinoid system is particularly active and involved in brain development and synaptic maturation. Since the adolescent brain is undergoing rapid structural and functional changes, external substances like THC can interfere with these natural processes. Studies have shown that repeated exposure to cannabinoids during adolescence can lead to alterations in neural connectivity and regulation of endocannabinoid receptors, precisely because the system is actively engaged in development during this life stage.
Effects of Cannabis on Adolescent Brain Development
The human brain continues to develop into early adulthood, undergoing key changes in structure, neural connectivity, and executive functions. Adolescence is a critical period during which the prefrontal cortex — responsible for planning, self-control, decision-making, and working memory — completes its maturation. It is precisely during this period that many adolescents experiment with cannabis use, but scientific evidence indicates that frequent use can have negative effects on brain development.
Evidence from neuroimaging and neuropsychological studies suggests that regular cannabis (coming from cannabis seeds) use during adolescence may be associated with differences in brain structure and functional connectivity compared to peers who do not use cannabis. Some longitudinal studies have found that adolescents with cannabis use disorders show reduced connectivity between the anterior cingulate and certain areas of the frontal cortex, regions crucial for cognitive control and emotion regulation. These alterations have been linked to lower IQ scores and slower cognitive performance over time (studies according to PubMed).
Other studies indicate that heavy cannabis use in adolescents is associated with changes in both brain structure and function, including variations in gray and white matter and in the distribution of brain metabolites, although the precise causal relationship remains complex (studies according to PubMed).
Cognitive consequences include difficulties with attention, memory, learning, and decision-making — all critical for academic and social success. Research suggests that these effects may be more pronounced in individuals who begin using cannabis at a very young age and with high frequency.
Additionally, clinical studies and meta-analyses have found associations between adolescent cannabis use and an increased risk of psychotic disorders, depression, and dependency, although the direct causal link and exact magnitude of risk may vary based on individual predispositions and environmental contexts. A study published in JAMA Psychiatry observed that adolescents who use cannabis before the age of 15 show a significantly higher likelihood of experiencing mental and physical health problems in adulthood, suggesting that early interference with brain development can have lasting effects beyond adolescence.
Studies on Cannabis Use Among Adolescents in Europe and Worldwide
Epidemiological data show that cannabis use is present in many regions of the world and often begins during adolescence. According to international reports and European surveys, a significant proportion of school-aged youth have tried cannabis at least once, although prevalence can vary between countries and regions. In Europe, studies such as those conducted by the EMCDDA indicate that millions of adolescents and young adults report cannabis use over the course of a year, although percentages vary from one country to another.
A recent report from the World Health Organization (WHO) highlights that a notable portion of 15-year-olds has used cannabis at least once in recent years, although the most recent data show a slight decline in some cohorts compared to previous years. These reports emphasize that cannabis use is often part of a broader pattern of other substance use and risky behaviors among adolescents.
It is important to note that cultural, legislative, and risk perception differences play a significant role in usage rates. In countries where legalization or decriminalization for adult use is more advanced, such as certain regions of the United States or Canada, an increase in youth usage rates has been observed, although the data remain a subject of debate and ongoing study.
At the same time, global monitoring indicates that the average adolescent tends to start using cannabis before the age of 20, with the typical age of first use around 15–19 years. This makes early understanding of the associated risks and targeted educational interventions crucial.
Conclusions
Understanding the effects of cannabis on adolescents requires a balanced and evidence-based approach: while cannabis can have therapeutic uses in controlled clinical settings, recreational use during adolescence is associated with numerous specific risks related to brain development. Science suggests that the developing brain is particularly vulnerable to chemical interference and that repeated exposure to cannabinoids, particularly high-dose THC, can affect the structure and function of neural circuits critical for cognition, learning, and self-control.
It is important to remember that not all adolescents who use cannabis (from weed seeds) will experience severe effects, but factors such as age of initiation, frequency of use, dosage, and individual predispositions contribute to the overall risk profile. Prevention, informed education, and harm reduction strategies remain essential tools for protecting young people, especially in light of changing legislation and increasingly permissive public perceptions.
For parents, educators, and policymakers, the available data highlight the need to communicate accurate, evidence-based information about the potential risks of cannabis use at a young age, while promoting an open, supportive, and public health–oriented dialogue.
